Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Acromegaly and Vertebral Fractures: Facts and Questions
Andrea Giustina
Trends in Endocrinology and Metabolism (2020) Vol. 31, Iss. 4, pp. 274-275
Closed Access | Times Cited: 40

Showing 1-25 of 40 citing articles:

Multidisciplinary management of acromegaly: A consensus
Andrea Giustina, Garni Barkhoudarian, Albert Beckers, et al.
Reviews in Endocrine and Metabolic Disorders (2020) Vol. 21, Iss. 4, pp. 667-678
Open Access | Times Cited: 273
A Pituitary Society update to acromegaly management guidelines
Maria Fleseriu, Beverly M. K. Biller, Pamela U. Freda, et al.
Pituitary (2020) Vol. 24, Iss. 1, pp. 1-13
Open Access | Times Cited: 249
Clinical Biology of the Pituitary Adenoma
Шломо Мелмед, Ursula B. Kaiser, M. Beatriz S. Lopes, et al.
Endocrine Reviews (2022) Vol. 43, Iss. 6, pp. 1003-1037
Open Access | Times Cited: 172
Acromegaly: pathogenesis, diagnosis, and management
Maria Fleseriu, Fabienne Langlois, Dawn Shao Ting Lim, et al.
The Lancet Diabetes & Endocrinology (2022) Vol. 10, Iss. 11, pp. 804-826
Closed Access | Times Cited: 132
Consensus on criteria for acromegaly diagnosis and remission
Andrea Giustina, Nienke R. Biermasz, Felipe F. Casanueva, et al.
Pituitary (2023)
Open Access | Times Cited: 77
Consensus Statement on Vitamin D Status Assessment and Supplementation: Whys, Whens, and Hows
Andrea Giustina, John P. Bilezikian, Robert A. Adler, et al.
Endocrine Reviews (2024) Vol. 45, Iss. 5, pp. 625-654
Open Access | Times Cited: 69
COVID-19 and the pituitary
Stefano Frara, Agnese Allora, Laura Castellino, et al.
Pituitary (2021) Vol. 24, Iss. 3, pp. 465-481
Open Access | Times Cited: 92
Radiological Thoracic Vertebral Fractures are Highly Prevalent in COVID-19 and Predict Disease Outcomes
Luigi di Filippo, Anna Maria Formenti, Mauro Doga, et al.
The Journal of Clinical Endocrinology & Metabolism (2020) Vol. 106, Iss. 2, pp. e602-e614
Open Access | Times Cited: 90
Pilot study to define criteria for Pituitary Tumors Centers of Excellence (PTCOE): results of an audit of leading international centers
Andrea Giustina, Meliha Melin Uygur, Stefano Frara, et al.
Pituitary (2023) Vol. 26, Iss. 5, pp. 583-596
Open Access | Times Cited: 34
Modern approach to resistant acromegaly
Andrea Giustina, Luigi di Filippo, Melin Uygur, et al.
Endocrine (2023) Vol. 80, Iss. 2, pp. 303-307
Closed Access | Times Cited: 22
High Prevalence of Vertebral Fractures Associated With Preoperative GH Levels in Patients With Recent Diagnosis of Acromegaly
Stefano Frara, Meliha Melin Uygur, Luigi di Filippo, et al.
The Journal of Clinical Endocrinology & Metabolism (2022) Vol. 107, Iss. 7, pp. e2843-e2850
Open Access | Times Cited: 28
New tools for bone health assessment in secreting pituitary adenomas
Meliha Melin Uygur, Stefano Frara, Luigi di Filippo, et al.
Trends in Endocrinology and Metabolism (2023) Vol. 34, Iss. 4, pp. 231-242
Closed Access | Times Cited: 17
Role of vitamin D in diabetic retinopathy: Pathophysiological and clinical aspects
Francesco Tecilazich, Anna Maria Formenti, Andrea Giustina
Reviews in Endocrine and Metabolic Disorders (2020) Vol. 22, Iss. 4, pp. 715-727
Open Access | Times Cited: 49
Hyperprolactinemia and bone
Luigi di Filippo, Mauro Doga, Eugenia Resmini, et al.
Pituitary (2020) Vol. 23, Iss. 3, pp. 314-321
Closed Access | Times Cited: 43
A Comparative Update on the Neuroendocrine Regulation of Growth Hormone in Vertebrates
Emilio J. Vélez, Suraj Unniappan
Frontiers in Endocrinology (2021) Vol. 11
Open Access | Times Cited: 39
Effects of Medical Treatment of Prostate Cancer on Bone Health
Anna Maria Formenti, Alberto Dalla Volta, Luigi di Filippo, et al.
Trends in Endocrinology and Metabolism (2021) Vol. 32, Iss. 3, pp. 135-158
Closed Access | Times Cited: 35
Cholecalciferol Use Is Associated With a Decreased Risk of Incident Morphometric Vertebral Fractures in Acromegaly
Sabrina Chiloiro, Stefano Frara, Irene Gagliardi, et al.
The Journal of Clinical Endocrinology & Metabolism (2023) Vol. 109, Iss. 1, pp. e58-e68
Open Access | Times Cited: 15
Acromegaly and Bone: An Update
Andrea Giustina
Endocrinology and Metabolism (2023) Vol. 38, Iss. 6, pp. 655-666
Open Access | Times Cited: 15
The optimal numerosity of the referral population of pituitary tumors centers of excellence (PTCOE): A surgical perspective
Pietro Mortini, Gianluca Nocera, Francesca Roncelli, et al.
Reviews in Endocrine and Metabolic Disorders (2020) Vol. 21, Iss. 4, pp. 527-536
Closed Access | Times Cited: 34
Impact of the diagnostic delay of acromegaly on bone health: data from a real life and long term follow-up experience
Sabrina Chiloiro, Antonella Giampietro, Irene Gagliardi, et al.
Pituitary (2022) Vol. 25, Iss. 6, pp. 831-841
Open Access | Times Cited: 21
New insights into the vitamin D/PTH axis in endocrine-driven metabolic bone diseases
Luigi di Filippo, John P. Bilezikian, Ernesto Canalis, et al.
Endocrine (2024) Vol. 85, Iss. 3, pp. 1007-1019
Closed Access | Times Cited: 4
Results from ACROCOVID: an international survey on the care of acromegaly during the COVID-19 era
Andrea Giustina, Ewen Legg, Bruno Mario Cesana, et al.
Endocrine (2021) Vol. 71, Iss. 2, pp. 273-280
Open Access | Times Cited: 25
Impaired Bone Microarchitecture in Premenopausal Women With Acromegaly: The Possible Role of Wnt Signaling
Paula P B Silva, Rosa Maria Rodrigues Pereira, Liliam Takayama, et al.
The Journal of Clinical Endocrinology & Metabolism (2021) Vol. 106, Iss. 9, pp. 2690-2706
Open Access | Times Cited: 24
Glucose metabolism outcomes in acromegaly patients on treatment with pasireotide-LAR or pasireotide-LAR plus Pegvisomant
Sabrina Chiloiro, Antonella Giampietro, Felicia Visconti, et al.
Endocrine (2021) Vol. 73, Iss. 3, pp. 658-666
Open Access | Times Cited: 23
Determinants of skeletal fragility in acromegaly: a systematic review and meta-analysis
Cláudia Ribeiro de Moura, Sara Campos Lopes, Ana Margarida Monteiro
Pituitary (2022) Vol. 25, Iss. 6, pp. 780-794
Closed Access | Times Cited: 15
Page 1 - Next Page

Scroll to top